What are the latest figures on the tissue heart valves market’s size and projected CAGR?
The tissue heart valves market size has grown steadily in recent years. It will grow from $1.48 billion in 2024 to $1.53 billion in 2025 at a compound annual growth rate (CAGR) of 3.1%. The growth in the historic period can be attributed to the growing prevalence of lifestyle diseases, rising healthcare expenditure, increasing elderly population, increase in cardiac & pathological disorders, and growing incidences of heart diseases.
The tissue heart valves market size is expected to see steady growth in the next few years. It will grow to $1.70 billion in 2029 at a compound annual growth rate (CAGR) of 2.7%. The growth in the forecast period can be attributed to the increasing prevalence of cardiovascular diseases, the rise in popularity of sutureless procedures, the growing aging population, the growing demand for cardiovascular treatments, and increasing healthcare investments. Major trends in the forecast period include technological innovations, innovative culture systems, advancements in imaging technologies, advancements in surgical techniques, and expansion in emerging market
Get Your Free Sample of The Global Tissue Heart Valves Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21302&type=smp
Which Market drivers have played a significant role in driving the tissue heart valves market?
The increasing prevalence of cardiovascular diseases is expected to propel the growth of the tissue heart valves market going forward. Cardiovascular diseases (CVDs) refer to a group of disorders affecting the heart and blood vessels, including conditions such as heart attacks, strokes, and hypertension. The increasing prevalence of cardiovascular diseases (CVDs) is primarily driven by factors such as unhealthy lifestyles, aging populations, increased prevalence of risk factors, poor diets, physical inactivity, smoking, stress, and urbanization, leading to higher rates of heart-related disorders globally. Tissue heart valves are crucial in addressing cardiovascular diseases (CVDs) by providing a biocompatible, durable, and less thrombogenic solution for patients requiring valve replacement, improving long-term heart function, and reducing the risk of complications. For instance, in September 2024, according to a report published by the Heart Failure Society of America (HFSA), a US-based professional organization company, approximately 6.7 million Americans aged 20 and older are currently living with heart failure (HF), with projections indicating this number will increase to 8.7 million by 2030, 10.3 million by 2040, and 11.4 million by 2050 respectively. Therefore, the increasing prevalence of cardiovascular diseases drives the growth of the tissue heart valve market.
What are the key segments within the tissue heart valves market?
The tissue heart valves market covered in this report is segmented –
1) By Type: Stented Tissue Heart Valves, Stentless Tissue Heart Valves
2) By Valve Type: Aortic, Mitral, Tricuspid, Pulmonary
3) By End-User: Hospitals, Ambulatory Surgical Centers, Other End-Users
Subsegments:
1) By Stented Tissue Heart Valves: Bovine Pericardial Valves, Porcine Valves
2) By Stentless Tissue Heart Valves: Bovine Pericardial Stentless Valves, Homograft Valves
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/tissue-heart-valves-global-market-report
Which key players are shaping the tissue heart valves market?
Major companies operating in the tissue heart valves market are Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, Edwards Lifesciences Corporation, LivaNova PLC, Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, LifeNet Health Inc., TTK Healthcare Ltd., Braile Biomédica, On-X Life Technologies Inc., Anteris Technologies Ltd., Labcor Laboratórios Ltd., CARDION s.r.o., CryoLife Inc., Colibri Heart Valve LLC, Foldax Inc., Balance Medical Technologies Co. Ltd., MiCardia Corporation, Neovasc Inc.
Which transformative trends will shape the tissue heart valves market landscape?
Major companies operating in the tissue heart valves market are focusing on developing innovative products, such as surgical aortic tissue valves, to facilitate ease of use at implant and lifetime patient management. A surgical aortic tissue valve is a prosthetic heart valve made from biological tissue, typically used to replace a diseased or damaged aortic valve in heart surgery. For instance, in June 2024, Medtronic plc., an Ireland-based technology company, launched the Avalus Ultra valve, a next-generation surgical aortic tissue valve designed to enhance ease of use during implantation and support long-term patient management. Built on 10 years of clinical experience with the Avalus valve, it features a low valve profile, a polyetheretherketone (PEEK) base frame for consistent circularity and an industry-leading Effective Orifice Area (EOA) for improved blood flow. The valve also includes a radiopaque coil for clear visibility in future valve-in-valve procedures, offering long-term durability for patients with aortic stenosis.
How do regional factors impact the tissue heart valves market, and which region is the largest contributor?
North America was the largest region in the tissue heart valves market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tissue heart valves market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Tissue Heart Valves Market Report 2025 Offer?
The tissue heart valves market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Tissue heart valves are heart valves made from biological tissue (rather than mechanical materials) used in heart valve replacement surgeries. They are often used as an alternative to mechanical heart valves and are designed to mimic the function of natural heart valves.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21302
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
